Showing results (201-210 of 1,811) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|February 24, 2023
Impact of Cryopreservation on Extracorporeal Photopheresis (ECP)-Treated Leukocyte SubsetsAndrew D Trunk, Katherine Radwanski, Cheryl Heber, et al.Transplantation and Cellular Therapy|March 8, 2023
Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid LeukemiaTakaaki Konuma, Kensuke Matsuda, Yoshimitsu Shimomura, et al.Transplantation and Cellular Therapy|March 4, 2023
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple MyelomaRajshekhar Chakraborty, Jean Yi, Lisa Rybicki, et al.Transplantation and Cellular Therapy|March 6, 2023
Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled TrialMaryan M Ali, Tobias Gedde-Dahl, Liv T Osnes, et al.Transplantation and Cellular Therapy|March 6, 2023
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell TransplantationPongthep Vittayawacharin, Ghayda' E'Leimat, Benjamin J Lee, et al.Transplantation and Cellular Therapy|March 15, 2023
Frailty in Patients with Chronic Graft-versus-Host DiseaseNahid Rashid, Mukta Arora, Najla El Jurdi, et al.Transplantation and Cellular Therapy|March 15, 2023
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell LymphomaMariana Bastos-Oreiro, Laura Sanz-Villanueva, Paula Muñiz, et al.Transplantation and Cellular Therapy|February 3, 2023
Comparison of Patient and Provider Practices between Bone Marrow and Solid Organ Transplantation Programs for Patient Education on Increased Risk of Skin CancerChelsea Shope, Laura Andrews, Kelly Atherton, et al.Transplantation and Cellular Therapy|November 21, 2025
Impact of Conditioning Regimen Type on Outcomes in Pediatric Patients with De Novo Advanced Myelodysplastic Syndrome Undergoing Hematopoietic Stem Cell TransplantationSuguru Uemura, Daiichiro Hasegawa, Nao Yoshida, et al.Transplantation and Cellular Therapy|November 14, 2025
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World SettingBradley D Hunter, Matthew Lunning, Mazyar Shadman, et al.Pageof 182